Commure vs Microsoft Dragon Copilot
Both are bundles, and the bundles are aimed at different budgets. Commure is a roll up of Athelas, Augmedix and Memora Health in which the scribe is the entry point to autonomous coding, documentation integrity and claims automation, and it offers the only staffing spectrum in the category: fully automated notes, AI plus specialist review, or synchronous human documentation. Dragon Copilot is a clinical productivity platform inside the Microsoft estate, with role based editions and the fullest published account of its own limitations anywhere in this lane. If the problem you are solving is revenue cycle and you want one vendor from the microphone to the claim, Commure is built for that and Microsoft is not. If the problem is clinician documentation across a mixed workforce and your governance committee wants to read something, the reverse holds.
- The service tiers are the differentiator. Augmedix Go delivers AI drafted notes, Assist adds specialist review and Live provides synchronous human documentation, so a service line that cannot accept a draft only workflow has a route that does not involve changing vendors.
- Breadth of record system coverage at the low end of the market, documented across more than 50 systems including Epic, Oracle Health and MEDITECH, in ambulatory and acute settings.
- The scribe feeds coding and claims automation inside one company rather than through an integration, which is the whole reason this platform exists. For a group practice measuring the documentation programme on collections rather than on minutes, that alignment is the argument.
- Transparency is the gap. Commure names no model, publishes no accuracy or benchmark figure and no bias or fairness position. Microsoft publishes a transparency white paper naming its own error modes, a sub processor list and an explicit statement about accent and dialect underperformance.
- Role based products for nurses and radiologists rather than a scribe stretched across settings, plus multilingual multi party capture and generated clinical letters.
- A regulatory position that has been stated somewhere. Registration as a Class 1 device with the United Kingdom regulator and a published account of where the product is and is not intended to be used, against a platform whose scope now runs from ambient capture to claims with no published boundary.
Side by Side
| Axis | C Commure |
M Microsoft Dragon Copilot |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Ambient Scribes page.
Neither vendor publishes pricing for the tier a health system actually buys. Third party figures for Commure in the region of 29 to 59 dollars per user per month originate from competing scribe vendors and are not treated as vendor evidence here. Commure's KLAS First Look score of 93.3 comes from interviews with a selected customer sample and measures satisfaction rather than accuracy.
Commure's trust centre purpose limitation language permits processing customer data to deliver, improve and support its products, which is broad enough that a buyer should establish in contract what improve covers.